Dan Groman, Chief Technology Officer at Enfusion, Inc. (ENFN), sold 5,000 shares at $9.97 ($50K) on 2023-11-14, disclosed to the SEC on 2023-11-16.
Scheduled sale ($50k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ENFN | SELL | 2023-08-15 | $14K | — | Filing → |
| ENFN | SELL | 2023-08-14 | $15K | — | Filing → |
| ENFN | SELL | 2023-08-11 | $17K | — | Filing → |